Q3 2020 Sales Performance slide image

Q3 2020 Sales Performance

Our Trust commitments Innovation By using our science and technology to address health needs Performance By making our products affordable and available Trust By being a modern employer New medical innovations Develop differentiated, high-quality and needed medicines, vaccines and consumer healthcare products to improve health Global health Improve global health impact through R&D for infectious diseases that affect children and adolescents in developing countries focusing on HIV, malaria and TB Health security Help the world to better prepare for future disease outbreaks with pandemic potential, and tackle antimicrobial resistance Being a responsible business Reliable supply Commit to quality, safety and reliable supply of our products for patients and consumers Pricing Improve the health of millions of people each year by making our products available at responsible prices that are sustainable for our business Product reach Use access strategies to reach 800 million underserved people in developing countries with our products by 2025 Healthcare access Partner to improve disease prevention, awareness and access to healthcare services for 12 million people by 2025 Ethics and values Operate an ethical, values-driven culture, in which any issues are responded to swiftly and transparently Engaged people Achieve and maintain a competitive employee engagement score by 2022 Inclusion and diversity Accelerate our progress on inclusion and diversity, aiming for over 37% female representation in senior roles and recognition in global LGBT+ indices, by 2022 Health, wellbeing and development Be a leading company in how we support employee health, wellbeing and personal development Data and engagement Use data responsibly and transparently. Improve patient and scientific engagement Environment* Reduce our environmental impact by one quarter by 2030 We have announced new environmental sustainability goals - see next slide. We will report against these new targets from 2021 gsk 12
View entire presentation